Home » Topics » Regulatory

Regulatory
RSS

FDA approves sNDA for Votrient

April 30, 2012

First medicine approved in E.U. for Cushing's disease

April 25, 2012

Alimera announces first marketing authorization for Iluvien in E.U.

April 25, 2012

Novartis seeking approval in Japan of Glivec for new indication

April 17, 2012

Eisai launches new formulation of rufinamide in U.K.

April 16, 2012

European Commission approves Humira for new indication

April 12, 2012

Korlym now available in U.S.

April 11, 2012

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

April 10, 2012

New product approved for T-cell leukemia-lymphoma

March 30, 2012

Kiklin capsules approved in Japan

March 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 19, 2025.
Merck’s MK-2214 shows potential to slow Alzheimer’s pathology
BioWorld Science
Abnormal tau aggregation is a hallmark of Alzheimer’s disease (AD) and a major contributor to neurodegeneration, synaptic dysfunction, and progressive functional...
ONC-841 reduces SIGLEC10-mediated Aβ plaque formation
BioWorld Science
Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10) is a microglia-specific surface receptor in the central nervous system, whose expression has been...
Subtyping beats a path toward precision medicine in Alzheimer’s
BioWorld MedTech
Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding subtypes in Alzheimer’s disease is all...